editor
novel
sever
acut
respiratori
syndrom
coronaviru
diseas
caus
coronaviru
diseas
caus
current
pandem
present
drug
proven
effect
treatment
vaccin
avail
report
first
case
japanes
patient
sever
pneumonia
favor
outcom
receiv
treatment
ciclesonid
antiinflammatori
drug
japanes
man
consult
local
physician
fever
last
day
initi
treat
azithromycin
presumpt
diagnosi
pneumonia
howev
day
later
ill
day
refer
anoth
hospit
fever
persist
ill
day
patient
began
minocyclin
treatment
howev
respiratori
condit
worsen
ill
day
refer
yokohama
citi
univers
hospit
patient
past
histori
medic
hypertens
upon
arriv
hospit
patient
vital
sign
follow
glasgow
coma
scale
blood
pressur
mmhg
temperatur
puls
beat
per
minut
respiratori
rate
breath
per
minut
oxygen
satur
nonrebreath
mask
lmin
oxygen
lung
auscult
unremark
although
creactiv
protein
crp
level
high
mgl
patient
blood
cell
count
within
refer
rang
rel
high
percentag
neutrophil
low
percentag
lymphocyt
chest
radiographi
perform
day
reveal
diffus
infiltr
bilater
chest
ct
scan
show
multipl
peripher
domin
ground
glass
opac
ggo
infiltr
shadow
find
similar
april
letter
editor
patient
seen
hospit
patient
taxi
driver
report
contact
passeng
cough
possibl
strongli
suspect
polymeras
chain
reaction
pcr
test
order
patient
immedi
admit
intens
care
unit
infect
control
zone
intub
ventil
control
hypoxia
treatment
strategi
base
world
health
organ
recommend
support
care
includ
oxygen
therapi
fluid
manag
antibiot
secondari
bacteri
infect
ceftriaxon
azithromycin
hospit
day
ill
day
aspir
sputum
test
neg
pcr
analysi
howev
still
strongli
suspect
infect
wbc
count
normal
crp
level
remain
elev
ct
find
consist
oxygen
improv
hospit
day
ill
day
aspir
sputum
test
posit
oxygen
disturb
chest
xray
chang
persist
lopinavirritonavir
lpvr
total
dose
lopinavir
mgritonavir
mg
per
day
prescrib
howev
respiratori
statu
improv
therefor
hospit
day
ill
day
prescrib
ciclesonid
inhal
antiinflammatori
drug
peripher
inflammatori
lesion
follow
day
ill
day
oxygen
improv
patient
wean
gradual
ventil
final
hospit
day
ill
day
extub
figur
sinc
respiratori
condit
remain
stabl
discharg
home
hospit
day
ill
day
confirm
neg
pcr
test
chest
xray
patient
earlystag
may
show
sever
abnorm
mild
april
letter
editor
sever
diseas
condit
wherea
ct
scan
reveal
peripher
ggo
sever
case
find
seem
specif
differ
caus
acut
respiratori
distress
syndrom
viral
pneumonia
fewer
interstiti
chang
rather
peripher
alveolar
injuri
associ
inde
increas
marker
interstiti
disord
pulmonari
spd
decreas
lung
complianc
observ
patient
present
similar
featur
suspect
despit
first
pcr
test
neg
although
prior
treatment
lpvr
fail
improv
oxygen
treatment
ciclesonid
coincid
posit
outcom
fact
nasopharyng
swab
specimen
lpvr
administr
posit
ciclesonid
inhal
steroid
drug
suppress
asthmat
attack
decreas
airway
hyperrespons
well
immedi
delay
form
pulmonari
resist
induc
inhal
antigen
ciclesonid
suppress
product
tumor
necrosi
cytokin
interleukin
il
inhibit
eosinophil
infiltr
respiratori
tract
ciclesonid
local
activ
drug
convert
activ
metabolit
desisobutyrylciclesonid
hydrolas
esteras
inhal
bind
glucocorticoid
receptor
produc
potent
antiinflammatori
effect
furthermor
desisobutyrylciclesonid
revers
bind
fatti
acid
form
fatti
acid
conjug
lead
protract
retent
lung
tissu
aerosol
high
percentag
fine
particl
reach
peripher
airway
good
lung
penetr
rate
approxim
ciclesonid
low
system
side
effect
april
letter
editor
may
peripher
alveoli
conclus
report
case
sever
pneumonia
diagnos
correctli
base
typic
chest
ct
find
clinic
featur
favor
outcom
find
suggest
ciclesonid
inhal
may
improv
respiratori
statu
sever
pneumonia
worthi
studi
clinic
trial
